bioventus
-
Biologics
Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans
September 09, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has agreed to a nationwide contract with UnitedHealthcare…
Read More » -
Biologics
Bioventus Launches DUROLANE® SJ (1mL) in Australia and New Zealand; Receives Expanded Indications for DUROLANE (3mL)
August 12, 2019 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE SJ (1mL), and has received…
Read More » -
Biologics
Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics
June 06, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has entered into a development collaboration agreement with MTF…
Read More » -
Biologics
Bioventus Launches OSTEOAMP® SELECT Fibers
March 27, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching OSTEOAMP SELECT Fibers, an innovative addition to its…
Read More » -
Biologics
Bioventus Launches DUROLANE® in Malaysia and Selects Athrotech as Exclusive Distribution Partner
January 29, 2019 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA)…
Read More » -
Biologics
Bioventus Launches OSTEOMATRIX+® Biphasic Bone Graft
January 15, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching OSTEOMATRIX+, its next generation biphasic bone graft for…
Read More » -
Biologics
Susan M. Stalnecker Named to Bioventus Board of Managers
October 25, 2018 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Susan M. Stalnecker, former Vice…
Read More » -
Hospitals
Bioventus Receives ANVISA Approval to Market DUROLANE® in Brazil and Selects Pfizer as Exclusive Distribution Partner
October 02, 2018 HOOFDDORP, Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has received approval from Agência Nacional de Vigilância…
Read More » -
Financial
Bioventus Enters Into Definitive Agreement to Divest BMP Development Program to Viscogliosi Brothers, LLC
July 23, 2018 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has entered into a definitive agreement to divest…
Read More » -
Biologics
Bioventus Launches DUROLANE® in the US
March 05, 2018 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today launched DUROLANE, its single-injection, hyaluronic acid (HA) product used…
Read More » -
Biologics
Bioventus to Co-Develop Next Generation Bone Allograft with LifeLink
February 26, 2018 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has entered into an agreement with LifeLink Tissue…
Read More » -
Biologics
Bioventus to Continue Distributing SUPARTZ FX™ Through 2028
February 12, 2018 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has entered into an extension of its agreement…
Read More » -
Financial
Additional Strategic Funding for CartiHeal’s Ongoing AGILI-C™ IDE Clinical Study $2.5M boost by Bioventus brings latest investment round to $21M
KFAR SABA, ISRAEL and DURHAM, NC– January 31, 2018 CartiHeal, developer of the proprietary Agili-C implant for the treatment of…
Read More » -
Biologics
Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN®
September 13, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologics, today announced the first patients have been enrolled in…
Read More » -
Biologics
Bioventus Receives US FDA Approval for DUROLANE®
September 05, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has received US FDA approval…
Read More »